<DOC>
	<DOCNO>NCT02448212</DOCNO>
	<brief_summary>The purpose study evaluate bind novel tracer , [ 11C ] TASP0410699 , use Positron Emission Tomography ( PET ) scan without dose TS-121</brief_summary>
	<brief_title>Exploratory Study Using Positron Emission Tomography With TS-121 11CTASP0410699 Healthy Adult Male Subjects</brief_title>
	<detailed_description />
	<criteria>1 . Healthy male 18 55 year age ( time initial informed consent ) 2 . Body weight â‰¥ 50 kg 3 . Body Mass Index ( BMI ) 18 30 kg/m2 4 . Male subject partner childbearing potential must agree use appropriate effective measure contraception 90 day follow drug administration 1 . Prescription , overthecounter herbal medication , supplement , within 14 day study . 2 . Clinically significant abnormal electrocardiogram , physical examination , hematology , biochemistry , hormone , urinalysis value screen &amp; baseline . 3 . Significant history &amp; /or presence hepatic , renal , cardiovascular , hemodynamic , pulmonary , gastrointestinal , hematological , CNS , immunologic , ophthalmologic , metabolic , endocrine , oncological disease condition within last 5 year . 4 . Current use tobacco tobaccocontaining product , recent history alcohol drug abuse OR positive urine screen alcohol control substance screen baseline . 5 . History &amp; /or current evidence serologic positive result hepatitis B C , HIV . 6 . Donation acute loss 450 milliliter blood plasma , within 60 day study . 7 . Any subject receive treatment nonFDA approve drug within 30 day study screen . 8 . Subjects suffer claustrophobia . 9 . Current , past , anticipate exposure radiation workplace participation research study involve ionizing radiation would exceed yearly dose limit normal subject .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>PET</keyword>
	<keyword>Receptor Occupancy</keyword>
</DOC>